Illumina Inc $179.36

up +0.28


29/8/2014 04:00 PM  |  NASDAQ : ILMN  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get ILMN Trend Analysis - it has outperformed the S&P 500 by 109%

Partner Headlines

  1. Gilead, Jazz Among 4 Top Big Cap Medicals To Watch

    IBD
  2. The 4 Companies Teaming Up For A New Tool To Fight Cancer

    Benzinga
  3. Illumina Joins Drugmakers To Make Cancer Test System

    IBD
  4. Illumina: Making Markets By Unlocking The Genome

    IBD
  5. Illumina lines up key partners

    IBD
  6. Illumina Forms Partnerships With Big Pharma Firms

    IBD
  7. Stocks Open Higher, Turn Mixed; Illumina Rises, Autohome Slips

    IBD
  8. US Stock Futures Surge Ahead Of Economic Data

    Benzinga
  9. Markets Mostly Higher Despite Initial Negative Reaction From FOMC Minutes

    Benzinga
  10. Wedbush Upgrades Illumina To Outperform, Shares Rise

    Benzinga
  11. Stocks Shave Down Early Losses; Spirit Airlines, Illumina Climb

    IBD
  12. Markets Marginally Lower In Quiet Trading Session

    Benzinga
  13. UPDATE: Stifel Nicolaus Initiates Coverage on Illumina, Inc. at Buy, Announces ...

    Benzinga
  14. Benzinga's Top Initiations

    Benzinga
  15. Stifel Nicolaus Initiates Illumina At Buy

    Benzinga
  16. Stocks Hold Gains Midday; Walgreen Recoups Losses

    IBD
  17. UPDATE: Tigress Initiates Coverage On Illumina

    Benzinga
  18. Top Insider Sells Highlight: Illumina Inc.

    GuruFocus
  19. Celgene, Alexion Beat Estimates, But Biotechs Fall

    IBD
  20. Stock Indexes Nearly Flat, But Apparel, Paper, Internet Shine

    IBD
  21. Under Armour, Facebook Soar As Nasdaq Turns Positive

    IBD
  22. Illumina reports robust Q2

    IBD
  23. Stocks Open Low And Soft; Baidu, Kandi, Diamonback Rise

    IBD
  24. Facebook, Gilead Headline IBD 50's Top 5 Earnings

    IBD
  25. Illumina Names Tina S. Nova As Senior Vice Pres And General Manager Of ...

    Benzinga
  26. Some Stock Leaders Stay Firm Amid Pullback

    IBD
  27. Several Big Cap 20 Names Near Buy Points

    IBD
  28. Albany Molecular's Oso Buy Seen Boosting Earnings

    IBD
  29. Salix, Jazz Lead As Drugmakers Pace IBD 50 For Week

    IBD
  30. Stocks Mixed In Late Trade, But Growth Stocks Outperform

    IBD
  31. Nasdaq Showing Outperformance; GoPro Extends Gains

    IBD
  32. Novo, Other Medicals Display Healthy Action

    IBD
  33. 3 Hot Biotech Stocks Hitting Highs

    Benzinga
  34. Facebook Pops, But Key Indexes End Flat In Quiet Session

    IBD
  35. A Few Medical Research Stocks Break Out, Others Basing

    IBD
  36. Stocks Hold Near Highs; Illumina Breakout Gains Traction

    IBD
  37. Stocks Build On Gains Backed By Strong Volume

    IBD
  38. Stocks Show Solid Gains At Midday

    IBD
  39. Stocks Reverse Into Thin Losses; Joy Global, Illumina Rocket

    IBD
  40. Five Star Biotech Stock Watch: Illumina

    Benzinga
  41. Baron Funds Comments on Illumina Inc.

    GuruFocus
  42. Baron Funds Comments on Illumina Inc.

    GuruFocus
  43. Valeant, Tesla Working On Bases As Energy Dominates

    IBD
  44. Baron Funds Comments on Illumina Inc.

    GuruFocus
  45. Nasdaq Recovers After Early Weakness; Apple Rallies Again

    IBD
  46. Illumina Reports Filing of New Patent Infringement Case Against Ariosa ...

    Benzinga
  47. Gilead, Illumina Q1 Earnings Win Wall Street's Love

    IBD
  48. Stock Futures Mixed And Busy; Illumina Rockets, Cree Tumbles

    IBD
  49. Gilead, Illumina Crush Views

    IBD
  50. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
Trading Center